Sandra Silvestri, M.D., Ph.D.

Chief Medical Officer

Sandra Silvestri, M.D., Ph.D.,  joined Ipsen in 2023 as Executive Vice President, Chief Medical Officer and heading Global Medical Affairs, Patient Safety and Patient Affairs.

Prior to joining Ipsen, Sandra held multiple leadership roles at Sanofi, where she was most recently SVP Global Medical Head for General Medicine GBU, leading a team of 1,600 medical employees worldwide. She also held several leadership positions at Eli Lilly in multiple disease areas including diabetology, endocrinology, neuroscience, immunology, dermatology, and oncology.

Medical doctor, specialized in Endocrinology and Metabolic diseases, she holds a PhD in internal medicine and cardiovascular diseases and a Master II in pharmacogenetics. She has been an investigator in several clinical studies, published numerous book chapters as well as scientific articles in international journals, been a speaker in several national and international congresses, and from 2017 to April 2023 she has led the Gender Balance Board and Global Network at Sanofi. She stays active as a professor at the medical schools of the University of Florence, Italy, and Descartes University in Paris. She has lived in Italy, Denmark, USA, France, and speaks Italian, English and French.